Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study - Modi, S; Park, H; Murthy, R K (J Clin Oncol, 2020)